281 related articles for article (PubMed ID: 12219778)
1. Gnotobiotic piglets develop thrombotic microangiopathy after oral infection with enterohemorrhagic Escherichia coli.
Gunzer F; Hennig-Pauka I; Waldmann KH; Sandhoff R; Gröne HJ; Kreipe HH; Matussek A; Mengel M
Am J Clin Pathol; 2002 Sep; 118(3):364-75. PubMed ID: 12219778
[TBL] [Abstract][Full Text] [Related]
2. [Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome].
Allerberger F; Sölder B; Caprioli A; Karch H
Wien Klin Wochenschr; 1997 Sep; 109(17):669-77. PubMed ID: 9381722
[TBL] [Abstract][Full Text] [Related]
3. The role of virulence factors in enterohemorrhagic Escherichia coli (EHEC)--associated hemolytic-uremic syndrome.
Karch H
Semin Thromb Hemost; 2001 Jun; 27(3):207-13. PubMed ID: 11446654
[TBL] [Abstract][Full Text] [Related]
4. Enterohemorrhagic Escherichia coli O26:H11-Associated Hemolytic Uremic Syndrome: Bacteriology and Clinical Presentation.
Zimmerhackl LB; Rosales A; Hofer J; Riedl M; Jungraithmayr T; Mellmann A; Bielaszewska M; Karch H
Semin Thromb Hemost; 2010 Sep; 36(6):586-93. PubMed ID: 20865635
[TBL] [Abstract][Full Text] [Related]
5. Escherichia coli O157:H7 strains that express Shiga toxin (Stx) 2 alone are more neurotropic for gnotobiotic piglets than are isotypes producing only Stx1 or both Stx1 and Stx2.
Donohue-Rolfe A; Kondova I; Oswald S; Hutto D; Tzipori S
J Infect Dis; 2000 May; 181(5):1825-9. PubMed ID: 10823794
[TBL] [Abstract][Full Text] [Related]
6. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.
Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Komatsu A; Kamiya S
FEMS Immunol Med Microbiol; 2004 Jul; 41(3):219-26. PubMed ID: 15196571
[TBL] [Abstract][Full Text] [Related]
7. [Enterohemorrhagic Escherichia coli in hemolytic uremic syndrome in Chilean children. Evaluation of different technics in the diagnosis of the infection].
Prado V; Cordero J; Garreaud C; Olguin H; Arellano C; Nachar CL; Misraji A; Martínez J; Tous M; Rivas M
Rev Med Chil; 1995 Jan; 123(1):13-22. PubMed ID: 7569441
[TBL] [Abstract][Full Text] [Related]
8. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
[TBL] [Abstract][Full Text] [Related]
9. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
[TBL] [Abstract][Full Text] [Related]
10. Searching for a valid animal model of hemolytic uremic syndrome.
Laszik ZG; Blakey GL
Am J Clin Pathol; 2002 Sep; 118(3):323-5. PubMed ID: 12219773
[No Abstract] [Full Text] [Related]
11. Shiga-toxigenic Escherichia coli-inoculated neonatal piglets develop kidney lesions that are comparable to those in humans with hemolytic-uremic syndrome.
Pohlenz JF; Winter KR; Dean-Nystrom EA
Infect Immun; 2005 Jan; 73(1):612-6. PubMed ID: 15618202
[TBL] [Abstract][Full Text] [Related]
12. "Children on the frontline against E. coli": typical hemolytic-uremic syndrome.
Andersen H
Clin Lab Sci; 2005; 18(2):90-9. PubMed ID: 15916241
[TBL] [Abstract][Full Text] [Related]
13. [Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome in Argentina].
Rivero MA; Padola NL; Etcheverría AI; Parma AE
Medicina (B Aires); 2004; 64(4):352-6. PubMed ID: 15338982
[TBL] [Abstract][Full Text] [Related]
14. Localization of Shiga toxins of enterohaemorrhagic Escherichia coli in kidneys of paediatric and geriatric patients with fatal haemolytic uraemic syndrome.
Chaisri U; Nagata M; Kurazono H; Horie H; Tongtawe P; Hayashi H; Watanabe T; Tapchaisri P; Chongsa-nguan M; Chaicumpa W
Microb Pathog; 2001 Aug; 31(2):59-67. PubMed ID: 11453701
[TBL] [Abstract][Full Text] [Related]
15. Virulence profiles of Shiga toxin 2e-producing Escherichia coli isolated from healthy pig at slaughter.
Zweifel C; Schumacher S; Beutin L; Blanco J; Stephan R
Vet Microbiol; 2006 Oct; 117(2-4):328-32. PubMed ID: 16872761
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans.
Friedrich AW; Zhang W; Bielaszewska M; Mellmann A; Köck R; Fruth A; Tschäpe H; Karch H
Clin Infect Dis; 2007 Jul; 45(1):39-45. PubMed ID: 17554698
[TBL] [Abstract][Full Text] [Related]
17. Shiga toxin-associated hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: distinct mechanisms of pathogenesis.
Tarr PI
Kidney Int Suppl; 2009 Feb; (112):S29-32. PubMed ID: 19180128
[TBL] [Abstract][Full Text] [Related]
18. Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11.
Misselwitz J; Karch H; Bielazewska M; John U; Ringelmann F; Rönnefarth G; Patzer L
Pediatr Infect Dis J; 2003 Apr; 22(4):349-54. PubMed ID: 12690276
[TBL] [Abstract][Full Text] [Related]
19. Enterohaemorrhagic Escherichia coli in human medicine.
Karch H; Tarr PI; Bielaszewska M
Int J Med Microbiol; 2005 Oct; 295(6-7):405-18. PubMed ID: 16238016
[TBL] [Abstract][Full Text] [Related]
20. Enterohaemorrhagic Escherichia coli O26:H11/H-: a human pathogen in emergence.
Bielaszewska M; Zhang W; Mellmann A; Karch H
Berl Munch Tierarztl Wochenschr; 2007; 120(7-8):279-87. PubMed ID: 17715820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]